Previous Article | Next Article 
Journal of Virology, November 1998, p. 9054-9060, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Costimulation of Naive CD8+ Lymphocytes Induces CD4
Expression and Allows Human Immunodeficiency Virus Type 1 Infection
Scott G.
Kitchen,1
Yael D.
Korin,2
Michael D.
Roth,3
Alan
Landay,4 and
Jerome A.
Zack1,5,*
Division of
Hematology-Oncology1 and
Division of
Pulmonary & Critical Care,3 Department of
Medicine,
Department of Pathology & Laboratory
Medicine,2 and
Department of
Microbiology & Molecular Genetics,5 UCLA
School of Medicine, Los Angeles, California 90095, and
Department of Immunology & Microbiology, Rush
Presbyterian-St. Luke's Medical Center, Chicago, Illinois
606124
Received 15 May 1998/Accepted 17 July 1998
 |
ABSTRACT |
Human immunodeficiency virus type 1 (HIV-1) infection requires cell
surface expression of CD4. Costimulation of
CD8+/CD4
T lymphocytes by anti-CD3 and
anti-CD28 antibodies or by allogeneic dendritic cells induced
expression of CD4 and rendered these CD8 cells susceptible to HIV-1
infection. Naive CD45RA+ cells responded with greater
expression of CD4 than did CD45RO+ cells. CD8+
lymphocytes derived from fetal or newborn sources exhibited a greater
tendency to express CD4, consistent with their naive states. This
mechanism of infection suggests HIV-induced perturbation of the CD8 arm
of the immune response and could explain the generally rapid disease
progression seen in HIV-infected children.
 |
INTRODUCTION |
Human immunodeficiency virus type 1 (HIV-1) infection requires coordinated cell surface expression of CD4
as well as expression of one of several chemokine receptors, which
function as coreceptors for HIV-1 entry (1, 4, 9, 12, 13,
16). The two accessory molecules most prevalently used by HIV-1
as coreceptors for infection are CXCR4 and CCR5 (10). In
addition, the activation state of a cell affects many stages in the
viral life cycle, including entry, reverse transcription, integration,
and proviral expression (5, 6, 37, 42). Several studies have
recently examined differential regulation of levels of CXCR4 and CCR5
expression on potential HIV target cells following cell cycle
activation (2, 5, 6, 38, 40).
Optimal T-cell activation requires engagement of the T-cell receptor as
well as engagement of costimulatory molecules such as CD28 (7, 20,
22). Our laboratory recently examined the effects of
costimulation of primary peripheral blood lymphocytes (PBL) with
anti-CD3 and anti-CD28 monoclonal antibodies (MAbs) on reverse
transcription of HIV-1 (27). During these analyses, following stimulation, we noted a de novo appearance of CD4 on the
surface of cells that were previously CD8 single positive.
Because of the critical role of CD4 in HIV infection, in this study, we
further evaluated this phenomenon by analyzing enriched CD8+/CD4
lymphocytes from several human
sources, including fetal thymus, fetal spleen, umbilical cord blood,
and adult PBL. Stimulation either with mitogen (phytohemagglutinin
[PHA]) or with anti-CD3 or anti-CD28 MAbs alone failed to promote
expression of CD4 on any of these cells. In contrast, costimulation
provided by the combination of anti-CD3 and anti-CD28 MAbs or by
allogeneic dendritic cells during a mixed leukocyte reaction (MLR)
resulted in expression of CD4 on a subpopulation of previously
single-positive CD8 T cells. Depletion studies which enriched for
either naive (CD45RA+) or memory (CD45RO+) T
cells demonstrated that costimulation of the naive subset was primarily
responsible for the de novo acquisition of CD4. Expression of CXCR4
and/or CCR5 coreceptors was also noted on these stimulated cells.
Furthermore, we documented that CD8+/CD4
T
cells stimulated in this manner became susceptible to HIV-1 infection.
This mechanism of infection, which allows HIV-1 entry into a cell type
usually thought to be resistant to this virus, could have many
pathogenic consequences, including increasing the reservoir of infected
cells and perturbing the CD8 arm of the immune response. Heightened
expression of CD4 by the naive CD8+/CD4
T
cells that predominate in fetal and newborn samples suggests that this
mechanism of infection may contribute to the more rapid disease
progression seen in the infected pediatric population.
 |
MATERIALS AND METHODS |
Cell purification.
Fresh peripheral blood was obtained from
healthy, HIV-seronegative donors. Spleen and thymus from fetuses
ranging in gestational age from 20 to 24 weeks were obtained from the
Anatomical Gift Foundation (Woodbine, Ga.), and umbilical cord blood
was obtained from the UCLA Cord Blood Bank, as approved by the UCLA
Human Subjects Protection Committee. Peripheral blood, fetal spleen,
and cord blood mononuclear cells were isolated following Ficoll-Hypaque (Sigma, St. Louis, Mo.) separation. Cells were then passed through a
nylon wool column to remove B cells and monocytes and further purified
to remove macrophages by adherence to plastic for a minimum of 2 h. For purification of CD4
,
CD4
/CD45RA
, or
CD4
/CD45RO
populations, cells were
incubated on ice with saturating amounts of MAbs either for CD4, CD4
and CD45RA, or CD4 and CD45RO (Becton Dickinson, San Jose, Calif.),
respectively. Cells were extensively washed, resuspended in RPMI 1640 with L-glutamine (Bio-Whittaker, Walkersville, Md.), and
subjected to panning in flasks coated with goat anti-mouse antibodies
(Sigma) which depleted cells expressing either CD4, CD4 and CD45RA, or
CD4 and CD45RO, respectively. Postdepletion purity was determined by
flow cytometry.
Cell culture and cell activation.
Following purification,
cells were cultured in RPMI 1640 containing penicillin (100 U/ml),
streptomycin (100 µg/ml) (Sigma), and 10% human AB serum (Gemini
Bioproducts, Inc., Calabasas, Calif.). Cells were stimulated by culture
in either PHA (1 µg/ml; Sigma), anti-CD3 MAb (1 µg/ml) immobilized
on goat anti-mouse antibody-coated plates, or immobilized anti-CD3 MAb
and soluble anti-CD28 MAb at a concentration of 1 µg/ml. Dendritic
cells were prepared from fresh human PBL as described
previously (23). MLRs were performed by the
addition of 200,000 CD4
,
CD4
/CD45RA
, or
CD4
/CD45RO
cells to 10,000 allogeneic
dendritic cells in a 96-well plate in a total volume of 200 µl of
RPMI 1640 containing antibiotics, 10% human AB serum, and interleukin
12 (IL-12; 1 ng/ml; Pharmingen, San Diego, Calif.).
Flow cytometry.
Fluorescein isothiocyanate (FITC)-,
phycoerythrin (PE)-, biotin-, or allophycocyanin-conjugated MAbs
specific for human CD3, CD4, CD8, CD45RA, and CD45RO and the activation
markers CD25, CD69, and CD71 were obtained from Becton Dickinson.
Biotinylated antibodies were stained in a second step with streptavidin
conjugated with red 613 (Becton Dickinson). Conjugated MAbs specific
for CXCR4 and CCR5 were obtained from Pharmingen. Four-color
acquisition was performed with a FACStarPlus flow cytometer
(Becton Dickinson). Immunophenotypic analysis was performed with the
Cellquest program (Becton Dickinson). Live cells were gated by using
forward-versus-side scatter dot plots. Conjugated mouse isotype
antibodies were used as a negative control for gating of those cells
staining negative for a cell surface marker. As a control for
autofluorescence, unstimulated populations were acquired by the
FACStarPlus, using instrument settings determined by
unstimulated cells separately stained with either an FITC-, PE-, red
613-, or allophycocyanin-conjugated isotype control MAb. Stimulated
populations were likewise acquired, using instrument settings from
single-color-stained stimulated cells.
RT-PCR.
RNA was extracted from cells by using the RNeasy
column extraction procedure (Qiagen, Chatsworth, Calif.) and DNase
treated as described elsewhere (25). Reverse transcriptase
PCR (RT-PCR) for CD4 mRNA was performed as previously described, using
primers specific for CD4 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), with one of each set of primers being radiolabeled, to quantitate cellular RNA input (25). The sample was
subsequently analyzed by 6% polyacrylamide gel electrophoresis
(25) followed by radioanalytic image quantitation.
Virus stocks and infection.
HIV-1NL-thy has been
previously described (21, 30); virus stocks were obtained by
electroporation of CEM cells with plasmid containing full-length
infectious DNA (30 µg), followed by coculture with uninfected CEM
cells. Quantitation of p24gag in virally
infected culture supernatants was performed by enzyme-linked immunosorbent assay (Coulter, Hialeah, Fla.). Determination of infectious units of virus per milliliter was performed by PCR on
infected PBL as described previously (26). It was determined that 1 ng of p24 is approximately equivalent to 125 infectious units.
Infection of stimulated and unstimulated PBL was performed by the
addition of HIV-1NL-thy virus stock with Polybrene (10 µg/ml) at a multiplicity of infection of approximately 0.5 for 1 h as described previously (27). For CD4 blocking
experiments, 100 µg of CD4 immunoglobulin G per ml (19)
was added to the virus stock immediately before infection and
subsequently to cultures following infection.
 |
RESULTS |
Stimulation of CD4
PBL.
To determine the effects
of different types of stimulation on the expression of surface markers
on subsets of human PBL, CD4- or CD8-depleted cells from peripheral
blood of adults were stimulated in the presence of either PHA, anti-CD3
MAb, or anti-CD28 MAb or costimulated with anti-CD3 and anti-CD28 MAbs.
Three days later, the cells were analyzed for expression of CD4 and CD8
by flow cytometry. Costimulation resulted in de novo expression of CD4 (along with CD8) on cells that previously lacked CD4 expression. Stimulation by either PHA, anti-CD3 alone (Fig.
1A), or anti-CD28 alone (data not shown)
did not result in this phenotype. Costimulation of cells lacking CD8
cell surface expression likewise resulted in de novo expression of CD8;
however, expression of CD8 on these CD4+ cells was less
frequent than the expression of CD4 on previously CD8+
cells. Costimulated cells also expressed greater levels of the activation markers CD25, CD69, and CD71, thus confirming their activated state (not shown).

View larger version (36K):
[in this window]
[in a new window]

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Stimulation of CD8-depleted (top row) and
CD4-depleted (bottom row) PBL. PBL were depleted by panning and
stimulated with either PHA, anti-CD3 MAb, or anti-CD3 and anti-CD28
MAbs. Cells were analyzed by flow cytometry for expression of CD4 (red
613) and CD8 (allophycocyanin) following 3 days of stimulation.
CD4+/CD8+ cells were not observed when cells
were stimulated with anti-CD28 alone (data not shown). The percentage
of cells in each quadrant is shown. (B) CD4 mRNA expression in
costimulated and unstimulated CD4-depleted leukocytes. PBL were
depleted of CD4+ cells by panning and stimulated
with anti-CD3 and anti-CD28 MAbs or cultured unstimulated in parallel.
Three days later, RNA was purified from the CD4-depleted and undepleted
populations and subjected to RT-PCR for CD4 (top panel) and GAPDH
(middle panel). Standards consisting of dilutions of undepleted
stimulated PBL were amplified in parallel and are indicated by number
of input cell equivalents. The primers for CD4 mRNA amplify a region
containing an RNA splice site and therefore do not amplify
potentially contaminating chromosomal DNA sequences. A "no RT"
control was performed for GAPDH (bottom panel) to detect the
presence of contaminating DNA sequences, of which there were none. The
ratio of the level of CD4 mRNA signal to GAPDH signal was 22-fold
higher in the costimulated CD8+ population than in the
unstimulated CD8+ population.
|
|
Due to the importance of CD4 for HIV infection, we focused on
characterizing the expression of CD4 on CD8 single-positive
T
lymphocytes. To determine whether expression of CD4 on the surface
of
the cell was the result of greater CD4 mRNA transcription,
CD4
mRNA levels were assessed in purified CD4

cells following
costimulation, using RT-PCR. Overall levels of
CD4 mRNA (in
relation to GAPDH expression) were approximately
20-fold higher in
CD4

populations following costimulation than in
unstimulated CD8
+ cells (Fig.
1B). Therefore, costimulation
by anti-CD3 and anti-CD28
MAbs resulted in increased transcription and
protein expression
of CD4 in cells that were previously
CD4

, consistent with the increase in cell surface
expression.
Phenotypic analysis of CD8+/CD4
lymphocytes.
Adult CD8+/CD4
PBL are of predominantly two functional phenotypes:
CD45RA+, which is thought to indicate cells that have not
encountered sufficient stimulatory signals, and CD45RO+,
the memory phenotype which is found on cells thought to have previously
responded to antigenic stimulation (11, 32). Expression of
CD45RA and CD45RO is mostly reciprocal on naive and memory T
lymphocytes, respectively. However, there also exists a minor population of cells that express both isoforms; these cells are believed to more functionally resemble cells of the naive phenotype (3, 8, 34). To determine whether these phenotypes
influence the ability of a CD4
cell to express CD4
following costimulation, CD4
/CD45RA
and
CD4
/CD45RO
cells from adult PBL were
separately purified by negative selection, subjected to costimulation,
and examined for expression of CD4 (Fig.
2). Three days following costimulation, a
greater percentage of cells expressing CD4 was observed in the
previously naive CD8+/CD45RO
population than
in the total CD8+ or CD8+/CD45RA
(memory/activated) population. The relative mean fluorescence intensity
(MFI) of CD4 was also greater in the costimulated
CD8+/CD45RO
population than in the
CD8+/CD45RA
population. These levels of CD4
expression, however, are 5- to 10-fold lower than the level of CD4
expression seen on bona fide costimulated CD4+ cells
cultured and examined in parallel (Fig. 1 and data not shown).
CD8+/CD45RO
cells displayed a greater
percentage of CD25, CD69, and CD71 than
CD8+/CD45RA
cells following activation,
confirming their differential susceptibility to costimulation (not
shown).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Costimulation of CD45RA- or CD45RO-depleted,
CD4-depleted PBL. PBL were depleted of either CD4, CD4 and CD45RA, or
CD4 and CD45RO cells and stimulated with anti-CD3 and anti-CD28 MAbs.
Three days following stimulation, cells were analyzed by flow cytometry
for CD4 (red 613) and CD8 (allophycocyanin). CD8-expressing cells were
gated, and CD4 expression was assessed. The gray histograms represent
CD4 expression in unstimulated cells, and the black histograms
represent CD4 expression in costimulated cells. Percentages of
CD4+ cells in the unstimulated populations were all less
than 0.2%. Percentages of costimulated CD4+ cells are
given within the respective gates. The MFI of CD4 expression in the
CD4+ gate is given below the respective histogram. The MFI
of true CD4+ cells cultured in parallel was 197 (not
shown).
|
|
Stimulation of CD8+/CD4
lymphocytes in an
MLR.
Lymphocytes are stimulated in vivo through contact with
antigen in the context of an antigen-presenting cell (APC). Dendritic cells are professional APCs capable of stimulating T lymphocytes to a
high degree of activation by presenting antigen on major histocompatibility complex (MHC) molecules while simultaneously expressing costimulatory ligands (36). To determine whether CD4 expression is induced on CD8+ lymphocytes in a
setting more closely resembling in vivo cellular activation, MLRs with
allogeneic dendritic cells were examined. Dendritic cells were
derived from a CD14+ population of PBL treated
with granulocyte-macrophage colony-stimulating factor and IL-4
(23). Purified allogeneic CD4
,
CD4
/CD45RA
, or
CD4
/CD45RO
PBL were then added to these
cultures and later examined for expression of CD4 on CD8+ T
cells. Seven days following coculture, CD4 expression was observed on
CD8+ lymphocytes (Fig. 3).
Similar to results seen with antibody costimulation, a greater
percentage of CD8+/CD45RO
cells than of
the CD8+/CD45RA
population responded by
expressing CD4. Interestingly, in contrast to antibody
costimulation, CD8+/CD45RO
cells responded
with greater levels of CD4 expression on those few cells
expressing CD4. The differences between these results and those
observed with anti-CD3 and anti-CD28 costimulation may reflect the
different methods of cellular activation or differences in the length
of time in culture. The percentage of cells expressing activation
markers CD71 and CD25 was also greater in the
CD8+/CD45RO
population than in the
CD8+/CD45RA
population (not
shown), indicating greater overall cellular activation. Thus,
costimulation during the process of antigen presentation also induces
CD4 expression on purified CD8+/CD4
T
lymphocytes, similar to that observed with antibody costimulation.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Allogeneic dendritic cell stimulation of
CD4 PBL populations. CD4-, CD4/CD45RA-, or
CD4/CD45RO-depleted cells were placed in an MLR mixture with purified
human allogeneic dendritic cells for 7 days and assessed for expression
of CD3 (FITC), CD4 (red 613), and CD8 (allophycocyanin) by flow
cytometry. CD4 expression was analyzed by gating on the CD3- and
CD8-expressing populations to distinguish T cells from dendritic cells,
which do not express CD3 (23). The light gray histograms
represent CD4 expression on the unstimulated depleted PBL, the darker
gray histogram represents CD4 expression in CD4-depleted PBL cultured
for 7 days in IL-12 in the absence of dendritic cells, and the black
histograms represent CD4 expression in cells cultured in the MLR. CD4
expression in the unstimulated and IL-12-cultured populations was less
than 0.9%. Percentages of stimulated CD4+ cells are given
within the respective gates. The MFI of CD4 expression in the
CD4+ gate is given below the respective histogram.
|
|
Stimulation of fetal CD4
lymphocytes.
The fetal
or newborn immune system is comprised of predominantly naive cells.
Typically greater than 95% of fetal T lymphocytes express CD45RA
(3, 8), whereas only 45 to 60% of circulating adult PBL
express this marker (3, 34). To determine whether this
difference influences the induction of expression of CD4 on
CD8+ lymphocytes, purified CD4-depleted adult PBL and
similarly purified fetal splenocytes were costimulated with anti-CD3
and anti-CD28 and cultured in parallel. Three days following
costimulation, in three of three experiments using different cell
donors, a greater percentage of CD8+ fetal
splenocytes than of adult PBL expressed CD4 following costimulation (Fig. 4). Costimulation of
CD4
lymphocytes derived from umbilical cord blood or from
fetal thymus induced expression of CD4, similar to that seen on fetal
splenocytes (data not shown). Thus, CD8+ lymphocytes
derived from very young humans responded to costimulation by more
readily expressing CD4 than did cells derived from adults. These
differences are consistent with the relative distribution of
CD45RA+ cells in each population.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
CD4 expression on costimulated cells derived from the
adult and the fetus. CD4-depleted adult PBL or fetal splenocytes were
analyzed for CD4 (PE) on gated CD8-expressing cells immediately
following purification and 3 days following costimulation with anti-CD3
and anti-CD28 MAbs. Percentages of cells within each gate are given.
Data are representative of three experiments using different cell
donors.
|
|
Expression of HIV coreceptors on costimulated CD8+
lymphocytes.
To determine whether CD8+ cells that have
been stimulated to express CD4 could potentially be susceptible to HIV
infection, cells were costimulated and analyzed for expression of the
two major coreceptors for HIV-1, CXCR4 and CCR5 (Fig.
5). Greater overall levels of both
coreceptors were seen on the costimulated CD8+ cells
expressing CD4 than on unstimulated or activated
CD8+/CD4
cells. In fact, the majority of
lymphocytes in this newly CD4+ population expressed both
coreceptors, suggesting that this population of cells might be
susceptible to infection by most, if not all, HIV-1 strains.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 5.
Expression of HIV-1 coreceptors CXCR4 and CCR5 on
costimulated adult PBL. CD4-depleted adult PBL were analyzed for CCR5
(FITC), CXCR4 (PE), CD8 (allophycocyanin), and CD4 (red 613) 3 days
following costimulation with anti-CD3 and anti-CD28 MAbs. Coreceptor
expression on the different CD8-expressing subsets was quantitated by
gating. Gates are denoted by black boxes in the left column. Cells
within the different gates expressing CCR5 and CXCR4 are represented on
the right. The percentage of cells single positive (SP) or double
positive (DP) for the indicated marker is given within each quadrant.
|
|
Susceptibility to HIV-1 infection.
To determine whether
expression of CD4 following costimulation renders the CD8+
cell susceptible to infection by HIV-1, CD4-depleted adult PBL and fetal splenocytes were exposed in parallel to
HIV-1NL-thy 3 days following stimulation. This CXCR4-tropic
virus contains the murine thy1.2 gene inserted into the
viral nef region, rendering productively infected cells
detectable by flow cytometry specific for the murine protein
(30). Thy1.2 expression was detected in CD8+
cells newly induced to express CD4 in both cultures (Fig.
6). The high levels of CD8 found on these
virus-expressing cells confirm their origin. No Thy1.2 expression was
detected in unstimulated cultures or in stimulated cultures pretreated
with CD4 linked to immunoglobulin G, a reagent which has previously
(19) been demonstrated to block infection (not shown).
Thus, infection of these cells occurred through a
CD4-mediated pathway. Although not directly tested here, the high
levels of CCR5 on costimulated CD8+/CD4+ cells
suggest that viruses tropic for this coreceptor should similarly infect
these cells, and very recent studies by Yang et al. have demonstrated
this to occur (41).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 6.
HIV-1 infection of costimulated, CD4-depleted adult PBL
and fetal splenocytes. CD4-depleted adult PBL were costimulated by
anti-CD3 and anti-CD28 MAbs for 3 days, assessed for CD4 (PE) on
CD8-expressing cells (see Fig. 4), and infected with
HIV-1NL-thy. Infected and mock-infected cells were cultured
for 1 week following infection and analyzed for CD8 (FITC), CD4 (PE),
and Thy1.2 (allophycocyanin) expression. (A) CD4 expression in
unstimulated CD8+ cells following 10 days in culture.
Thy1.2 expression in infected, unstimulated cells was not detectable
(not shown). (B) Costimulated cells following 10 days in culture. (C)
Phenotype of cells expressing Thy1.2, which was determined by gating on
the cells that were positive for Thy1.2. Four percent of the total
adult PBL and 5% of the total splenocyte population expressed Thy1.2.
Percentages of CD4 and CD8 expression are given within the quadrants.
|
|
 |
DISCUSSION |
Our results indicate that costimulation of purified
CD8+/CD4
lymphocytes induces CD4 expression.
The levels of CD4 expression on these cells, however, are lower than
those observed on bona fide CD4+ cells examined in
parallel. The CD4 molecule functions as a coreceptor in antigen
recognition during T-cell responses and thymic selection. CD4 binds to
MHC class II and appears to provide stability to weak-affinity T-cell
receptor-MHC interactions, and it is also involved in triggering
the signal transduction cascade in antigen-specific responses
(24). The biologic function of CD4 expression on
CD8+ cells is not known. However, induction of expression
of CD4 on the surface of a previously CD4
cell might
allow a more efficient interaction with an APC. The ability of the
naive population to express CD4 in greater amounts than memory cells
may reflect the functional requirement of this population to receive
additional signals from APCs to encourage differentiation into a memory
phenotype.
Our results and those recently reported by two other groups (17,
41) further indicate that induction of CD4 expression on
CD8+ cells renders these cells susceptible to HIV-1
infection. The lower levels of CD4 expression on these populations,
however, suggest that these cells may be less susceptible to infection in vivo than are CD4 single-positive cells. Infection of
CD8+ cells could have profound effects on altering cell
number and function. Late in HIV disease progression, CD8+
cell numbers significantly decline in the peripheral blood (18, 29, 31). Whether this is due to indirect means or to
virus-mediated killing is not known. However, recent clinical studies
have demonstrated the presence of HIV-1 proviral DNA in
CD8+ cells in the lungs of infected patients
(35). Furthermore, it has been reported that late in disease
progression, the major reservoir for HIV proviral sequences in the
peripheral blood is the CD8+ lymphocyte (28). It
is interesting to speculate that the high levels of CXCR4 present on
activated CD4-bearing CD8+ cells might influence the
acquisition of CXCR4-tropic virus strains seen late in disease. It is
not known how frequently CD8+ cells express CD4 in vivo,
although this phenomenon might occur most often in lymphoid tissues,
where costimulation occurs. We have recently shown that infection of an
immature CD8+/CD4+ thymocyte that undergoes
further differentiation into a CD8+/CD4
cell
results in CD8+ thymocytes that express HIV-1
(25). Thus, mechanisms such as infection of a
CD4+ precursor or de novo acquisition of CD4 may explain
the presence of proviral sequences in and loss of CD8+
cells during disease progression.
HIV-infected children display a more rapid disease progression than do
adults (15, 39). Approximately one out of four perinatally
infected children develops AIDS within the first year after birth, and
the remainder typically develop AIDS within a mean of approximately 6 years, in contrast to the median 10-year period seen in adults
(14, 15, 33). The abundance of naive cell types in the fetus
and newborn and the greater ability of the
CD8+/CD45RO
population to express CD4
following costimulation could influence infection of these cells and
contribute to the increased rate of disease progression in children.
 |
ACKNOWLEDGMENTS |
We thank W. Aft and L. Duarte for manuscript preparation, and we
thank I. S. Y. Chen and J. Ferbas for critical reading of the
manuscript. We also thank C. Hunter, S. Laforge, and M. Mendenhall for
technical assistance.
This work was supported by NIH grants AI36059, AI36554, and HL55205
(J.A.Z.) and grant 2CB-0160 from the Breast Cancer Research Program at
the University of California (M.D.R.). J.A.Z. is an Elizabeth Glaser
Scientist supported by the Pediatric AIDS Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Hematology-Oncology, Department of Medicine, UCLA School of Medicine
Center for the Health Sciences, 10833 Le Conte Ave., Los Angeles, CA 90095-1678. Phone: (310) 794-7765. Fax: (310) 825-6192. E-mail: jzack{at}ucla.edu.
 |
REFERENCES |
| 1.
|
Alkhatib, G.,
C. C. Broder, and E. A. Berger.
1996.
Cell-type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.
J. Virol.
70:5487-5494[Abstract/Free Full Text].
|
| 2.
|
Amara, A.,
S. L. Gall,
O. Schwartz,
J. Salamero,
M. Montes,
P. Loetscher,
M. Baggiolini,
J. L. Virelizier, and F. Arenzana-Seisdedos.
1997.
HIV coreceptor downregulation as antiviral principle: SDF-1 alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication.
J. Exp. Med.
186:139-146[Abstract/Free Full Text].
|
| 3.
|
Amlot, P. L.,
F. Tahami,
D. Chinn, and E. Rawlings.
1996.
Activation antigen expression on human T cells. I. Analysis by two-colour flow cytometry of umbilical cord blood, adult blood and lymphoid tissue.
Clin. Exp. Immunol.
105:176-182[Medline].
|
| 4.
|
Berson, J. F.,
D. Long,
B. J. Doranz,
J. Rucker,
F. R. Jirik, and R. W. Doms.
1996.
A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
J. Virol.
70:6288-6295[Abstract].
|
| 5.
|
Bleul, C. C.,
L. Wu,
J. A. Hoxie,
T. A. Springer, and C. R. Mackay.
1997.
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.
Proc. Natl. Acad. Sci. USA
94:1925-1930[Abstract/Free Full Text].
|
| 6.
|
Carroll, R. G.,
J. L. Riley,
B. L. Levine,
Y. Feng,
S. Kaushal,
D. W. Ritchey,
O. S. Bernstein,
C. R. Brown,
E. A. Berger,
C. H. June, and D. C. St. Louis.
1997.
Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells.
Science
276:273-276[Abstract/Free Full Text].
|
| 7.
|
Chambers, C. A., and J. P. Allison.
1997.
Co-stimulation in T cell responses.
Curr. Opin. Immunol.
9:396-404[Medline].
|
| 8.
|
Chheda, S.,
K. H. Palkowetz,
D. K. Rassin, and A. S. Goldman.
1996.
Deficient quantitative expression of CD45 isoforms on CD4+ and CD8+ T cell subpopulations and subsets of CD45RA(low)CD45RO(low) T cells in newborn blood.
Biol. Neonate
69:128-132[Medline].
|
| 9.
|
Choe, H.,
M. Farzan,
Y. Sun,
N. Sullivan,
B. Rollins,
P. D. Ponath,
L. Wu,
C. R. Mackay,
G. LaRosa,
W. Newman,
N. Gerard,
C. Gerard, and J. Sodroski.
1996.
The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.
Cell
85:1135-1148[Medline].
|
| 10.
|
Clapham, P. R., and R. A. Weiss.
1997.
Immunodeficiency viruses. Spoilt for choice of co-receptors.
Nature
388:230-231[Medline].
|
| 11.
|
Clement, L. T.
1992.
Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation.
J. Clin. Immunol.
12:1-10[Medline].
|
| 12.
|
Deng, H.,
R. Liu,
W. Ellmeier,
S. Choe,
D. Unutmaz,
M. Burkhart,
P. Di Marzio,
S. Marmon,
R. E. Sutton,
C. M. Hill,
C. B. Davis,
S. C. Peiper,
T. J. Schall,
D. R. Littman, and N. R. Landau.
1996.
Identification of a major co-receptor for primary isolates of HIV-1.
Nature
381:661-666[Medline].
|
| 13.
|
Dragic, T.,
V. Litwin,
G. P. Allaway,
S. R. Martin,
Y. Huang,
K. A. Nagashima,
C. Cayanan,
P. J. Maddon,
R. A. Koup,
J. P. Moore, and W. Paxton.
1996.
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.
Nature
381:667-673[Medline].
|
| 14.
|
The European Collaboratory Study.
1991.
Children born to women with HIV-1 infection: natural history and risk of transmission.
Lancet
337:253-260[Medline].
|
| 15.
|
The European Collaboratory Study.
1994.
Natural history of vertically acquired human immunodeficiency virus-1 infection.
Pediatrics
94:815-819[Abstract/Free Full Text].
|
| 16.
|
Feng, Y.,
C. C. Broder,
P. E. Kennedy, and E. A. Berger.
1996.
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.
Science
272:872-877[Abstract].
|
| 17.
|
Flamand, L.,
R. W. Crowley,
P. Lusso,
S. Colombini-Hatch,
D. M. Margolis, and R. C. Gallo.
1998.
Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis.
Proc. Natl. Acad. Sci. USA
95:3111-3116[Abstract/Free Full Text].
|
| 18.
|
Giorgi, J. V., and R. Detels.
1989.
T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort study.
Clin. Immunol. Immunopathol.
52:10-18[Medline].
|
| 19.
|
Hays, E. F.,
C. H. Uittenbogaart,
J. C. Brewer,
L. W. Vollger, and J. A. Zack.
1992.
In vitro studies of HIV-1 expression in thymocytes from infants and children.
AIDS
6:265-272[Medline].
|
| 20.
|
Janeway, C. A., Jr., and K. Bottomly.
1994.
Signals and signs for lymphocyte responses.
Cell
76:275-285[Medline].
|
| 21.
|
Jowett, J. B. M.,
V. Planelles,
B. Poon,
N. P. Shah,
M.-L. Chen, and I. S. Y. Chen.
1995.
The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle.
J. Virol.
69:6304-6313[Abstract].
|
| 22.
|
June, C. H.,
J. A. Ledbetter,
P. S. Linsley, and C. B. Thompson.
1990.
Role of the CD28 receptor in T-cell activation.
Immunol. Today
11:211-216[Medline].
|
| 23.
|
Kiertscher, S. M., and M. D. Roth.
1996.
Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4.
J. Leukoc. Biol.
59:208-218[Abstract].
|
| 24.
|
Killeen, N., and D. R. Littman.
1996.
The regulation and function of the CD4 coreceptor during T lymphocyte development.
Curr. Top. Microbiol. Immunol.
205:89-106[Medline].
|
| 25.
|
Kitchen, S. G.,
C. H. Uittenbogaart, and J. A. Zack.
1997.
Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection.
J. Virol.
71:5713-5722[Abstract].
|
| 26.
|
Kitchen, S. G., and J. A. Zack.
1997.
CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus.
J. Virol.
71:6928-6934[Abstract].
|
| 27.
|
Korin, Y., and J. A. Zack.
1998.
Progression to the G1 phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells.
J. Virol.
72:3161-3168[Abstract/Free Full Text].
|
| 28.
|
Livingstone, W. J.,
M. Moore, M.,
D. Innes,
J. E. Bell, and P. Simmonds.
1996.
Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group.
Lancet
348:649-654[Medline].
|
| 29.
|
Margolick, J. B.,
A. Munoz,
A. D. Donnenberg,
L. P. Park,
N. Galai,
J. V. Giorgi,
M. R. O'Gorman, and J. Ferbas.
1995.
Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study.
Nat. Med.
1:674-680[Medline].
|
| 30.
|
Planelles, V.,
A. Haislip,
E. S. Withers-Ward,
S. A. Stewart,
Y. Xie,
N. P. Shah, and I. S. Y. Chen.
1995.
A new reporter system for detection of viral infection.
Gene Ther.
2:369-376[Medline].
|
| 31.
|
Roederer, M.
1998.
Getting to the HAART of T cell dynamics.
Nat. Med.
4:145-146[Medline].
|
| 32.
|
Roth, M. D.
1994.
Interleukin 2 induces the expression of CD45RO and the memory phenotype by CD45RA+ peripheral blood lymphocytes.
J. Exp. Med.
179:857-864[Abstract/Free Full Text].
|
| 33.
|
Scarlatti, G.
1996.
Paediatric HIV infection.
Lancet
348:863-868[Medline].
|
| 34.
|
Schiavon, V.,
P. Roth,
W. E. Bolton,
J. P. Farcet,
A. Bensussan, and L. Boumsell.
1996.
Lymphocyte subsets in normal individuals: analysis by four color immunofluorescence and flow cytometry on whole blood.
Tissue Antigens
48:312-318[Medline].
|
| 35.
|
Semenzato, G.,
C. Agostini,
L. Ometto,
R. Zambello,
L. Trentin,
L. Chieco-Bianchi, and A. De Rossi.
1995.
CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1.
Blood
85:2308-2314[Abstract/Free Full Text].
|
| 36.
|
Steinman, R. M.
1991.
The dendritic cell system and its role in immunogenicity.
Annu. Rev. Immunol.
9:271-296[Medline].
|
| 37.
|
Stevenson, M.,
T. L. Stanwick,
M. P. Dempsey, and C. A. Lamonica.
1990.
HIV-1 replication is controlled at the level of T cell activation and proviral integration.
EMBO J.
9:1551-1560[Medline].
|
| 38.
|
Unutmaz, D., and D. R. Littman.
1997.
Expression pattern of HIV-1 coreceptors on T cells: implications for viral transmission and lymphocyte homing.
Proc. Natl. Acad. Sci. USA
94:1615-1618[Free Full Text].
|
| 39.
|
Wiznia, A. A.,
G. Lambert, and S. Pavlakis.
1996.
Pediatric HIV infection.
Med. Clin. North Am.
80:1309-1336[Medline].
|
| 40.
|
Wu, L.,
W. A. Paxton,
N. Kassam,
N. Ruffing,
J. B. Rottman,
N. Sullivan,
H. Choe,
J. Sodroski,
W. Newman,
R. A. Koup, and C. R. MacKay.
1997.
CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.
J. Exp. Med.
185:1681-1691[Abstract/Free Full Text].
|
| 41.
|
Yang, L. P.,
J. L. Riley,
R. G. Carroll,
C. H. June,
J. Hoxie,
B. K. Patterson,
Y. Ohshima,
R. J. Hodes, and G. Delespesse.
1998.
Productive infection of neonatal CD8+ T lymphocytes by HIV-1.
J. Exp. Med.
187:1139-1144[Abstract/Free Full Text].
|
| 42.
|
Zack, J. A.,
S. J. Arrigo,
S. R. Weitsman,
A. S. Go,
A. Haislip, and I. S. Y. Chen.
1990.
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.
Cell
61:213-222[Medline].
|
Journal of Virology, November 1998, p. 9054-9060, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zloza, A., Schenkel, J. M., Tenorio, A. R., Martinson, J. A., Jeziorczak, P. M., Al-Harthi, L.
(2009). Potent HIV-specific responses are enriched in a unique subset of CD8+ T cells that coexpresses CD4 on its surface. Blood
114: 3841-3853
[Abstract]
[Full Text]
-
Burke, B., Brown, H. J., Marsden, M. D., Bristol, G., Vatakis, D. N., Zack, J. A.
(2007). Primary Cell Model for Activation-Inducible Human Immunodeficiency Virus. J. Virol.
81: 7424-7434
[Abstract]
[Full Text]
-
Bernstein, H. B., Plasterer, M. C., Schiff, S. E., Kitchen, C. M. R., Kitchen, S., Zack, J. A.
(2006). CD4 Expression on Activated NK Cells: Ligation of CD4 Induces Cytokine Expression and Cell Migration. J. Immunol.
177: 3669-3676
[Abstract]
[Full Text]
-
Zloza, A., Al-Harthi, L.
(2006). Multiple populations of T lymphocytes are distinguished by the level of CD4 and CD8 coexpression and require individual consideration. J. Leukoc. Biol.
79: 4-6
[Full Text]
-
Stove, V., Van de Walle, I., Naessens, E., Coene, E., Stove, C., Plum, J., Verhasselt, B.
(2005). Human Immunodeficiency Virus Nef Induces Rapid Internalization of the T-Cell Coreceptor CD8{alpha}{beta}. J. Virol.
79: 11422-11433
[Abstract]
[Full Text]
-
Kitchen, S. G., Whitmire, J. K., Jones, N. R., Galic, Z., Kitchen, C. M. R., Ahmed, R., Zack, J. A.
(2005). The CD4 molecule on CD8+ T lymphocytes directly enhances the immune response to viral and cellular antigens. Proc. Natl. Acad. Sci. USA
102: 3794-3799
[Abstract]
[Full Text]
-
Zerhouni, B., Nelson, J. A. E., Saha, K.
(2004). CXCR4-Dependent Infection of CD8+, but Not CD4+, Lymphocytes by a Primary Human Immunodeficiency Virus Type 1 Isolate. J. Virol.
78: 12288-12296
[Abstract]
[Full Text]
-
Cochrane, A., Imlach, S., Leen, C., Scott, G., Kennedy, D., Simmonds, P.
(2004). High Levels of Human Immunodeficiency Virus Infection of CD8 Lymphocytes Expressing CD4 In Vivo. J. Virol.
78: 9862-9871
[Abstract]
[Full Text]
-
Potter, S. J., Lemey, P., Achaz, G., Chew, C. B., Vandamme, A.-M., Dwyer, D. E., Saksena, N. K.
(2004). HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy. J. Leukoc. Biol.
76: 562-570
[Abstract]
[Full Text]
-
Nascimbeni, M., Shin, E.-C., Chiriboga, L., Kleiner, D. E., Rehermann, B.
(2004). Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functions. Blood
104: 478-486
[Abstract]
[Full Text]
-
Kitchen, S. G., Jones, N. R., LaForge, S., Whitmire, J. K., Vu, B.-A., Galic, Z., Brooks, D. G., Brown, S. J., Kitchen, C. M. R., Zack, J. A.
(2004). CD4 on CD8+ T cells directly enhances effector function and is a target for HIV infection. Proc. Natl. Acad. Sci. USA
101: 8727-8732
[Abstract]
[Full Text]
-
Stebbing, J., Gazzard, B., Douek, D. C.
(2004). Where Does HIV Live?. NEJM
350: 1872-1880
[Full Text]
-
Brenchley, J. M., Hill, B. J., Ambrozak, D. R., Price, D. A., Guenaga, F. J., Casazza, J. P., Kuruppu, J., Yazdani, J., Migueles, S. A., Connors, M., Roederer, M., Douek, D. C., Koup, R. A.
(2004). T-Cell Subsets That Harbor Human Immunodeficiency Virus (HIV) In Vivo: Implications for HIV Pathogenesis. J. Virol.
78: 1160-1168
[Abstract]
[Full Text]
-
Zerhouni, B., Nelson, J. A. E., Saha, K.
(2004). Isolation of CD4-Independent Primary Human Immunodeficiency Virus Type 1 Isolates That Are Syncytium Inducing and Acutely Cytopathic for CD8+ Lymphocytes. J. Virol.
78: 1243-1255
[Abstract]
[Full Text]
-
Zloza, A., Sullivan, Y. B., Connick, E., Landay, A. L., Al-Harthi, L.
(2003). CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIV. Blood
102: 2156-2164
[Abstract]
[Full Text]
-
Agostini, C., Semenzato, G., Lieberman, J., Shankar, P., Swamy, M., Andersson, J.
(2002). Why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood
99: 1876-1878
[Full Text]
-
Kitchen, S. G., LaForge, S., Patel, V. P., Kitchen, C. M., Miceli, M. C., Zack, J. A.
(2002). Activation of CD8 T cells induces expression of CD4, which functions as a chemotactic receptor. Blood
99: 207-212
[Abstract]
[Full Text]
-
Imlach, S., McBreen, S., Shirafuji, T., Leen, C., Bell, J. E., Simmonds, P.
(2001). Activated Peripheral CD8 Lymphocytes Express CD4 In Vivo and Are Targets for Infection by Human Immunodeficiency Virus Type 1. J. Virol.
75: 11555-11564
[Abstract]
[Full Text]
-
McBreen, S., Imlach, S., Shirafuji, T., Scott, G. R., Leen, C., Bell, J. E., Simmonds, P.
(2001). Infection of the CD45RA+ (Naive) Subset of Peripheral CD8+ Lymphocytes by Human Immunodeficiency Virus Type 1 In Vivo. J. Virol.
75: 4091-4102
[Abstract]
[Full Text]
-
Kitchen, S. G., Killian, S., Giorgi, J. V., Zack, J. A.
(2000). Functional Reconstitution of Thymopoiesis after Human Immunodeficiency Virus Infection. J. Virol.
74: 2943-2948
[Abstract]
[Full Text]
-
SAVARINO, A., BOTTAREL, F., CALOSSO, L., FEITO, M. J., BENSI, T., BRAGARDO, M., ROJO, J. M., PUGLIESE, A., ABBATE, I., CAPOBIANCHI, M. R., DIANZANI, F., MALAVASI, F., DIANZANI, U.
(1999). Effects of the human CD38 glycoprotein on the early stages of the HIV-1 replication cycle. FASEB J.
13: 2265-2276
[Abstract]
[Full Text]